There was a story on the front page of the business section of the New York Times at the beginning of this month about a race to develop a new product in biotechnology. The title "Down on the Farm, A Donor: Genetically Altered Pigs Bred for Organ Transplants" (Weil). This race involves four small biotechnology companies whose recent progress has prompted some scientists to say that the first organ transplant from pig to human could occur within a year. Due to this major pharmaceutical and medical device companies are funding this research, which mean these small firms will not have to ask the government.

hould regulate private biotechnology firms.

This story brings into focus the tangle of issues that precipitates quandaries about biotechnology development. Biotechnology is a challenging domain to examine. This world is the great and expanding range of areas of research and development with commercial potential and implementations. Advances in genetic modification, manip

Some common words found in the essay are:
Transplants Weil, Thompson Biotechnology, York Times, Regulation Biotechnology, biotechnology firms, private biotechnology firms, private firms, private biotechnology, stem cell research, stem cell, biotech firms, playing god, government regulate, plants animals, cell research,
Approximate Word count = 663
Approximate Pages = 3 (250 words per page double spaced)